Thomas Fuchs, the Dean of Artificial Intelligence and Human Health at Mount Sinai in NYC, said AI will be needed to retain the standard of care in the U.S. Glioblastoma is one of the deadliest types of brain cancer, with the average patient living only eight months after diagnosis, according to the National Brain Tumor Society, a nonprofit. Two ambitious high school students -- Andrea Olsen, 18, from Oslo, Norway, and Zachary Harpaz, 16, from Fort Lauderdale, Florida -- are looking to change that. The teens partnered with Insilico Medicine, a Hong Kong-based medical technology company, to identify three new target genes linked to glioblastoma and aging. They used Insilico's artificial intelligence platform, PandaOmics, to make the discovery -- and now, they plan to continue researching ways to fight the disease with new drugs. Their findings about target genes were published on April 26 in Aging, a peer-reviewed biomedical academic journal.

AI platform Globality is giving small and medium businesses access to broader opportunities. In a post-Brexit, "America First" world, protectionism seems to be back in fashion, and globalization has become something of a dirty word. Since the 1990s, global trade has helped lift over a billion people out of poverty, driven sustained economic growth, lowered consumer prices, and delivered unprecedented freedoms to much of the world's population. Still, middle-income earners have seen their living standards stagnate, while many of the great leaps forward in automation are destroying the jobs of those least able to cope, with vastly greater levels of disruption feared. Large multinational companies still seem to be the greatest beneficiaries of a globalized marketplace. Small and medium-sized businesses, which constitute the bulk of the world's economy and drive most job creation, find it more difficult to make valuable connections that can lead to international trade opportunities and contracts with large organizations.